title: [Effects of Shenfu Injection on inflammatory cytokines during cardiopulmonarbypass in infants].
abstract: OBJECTIVE
  To evaluate the effects of Shenfu Injection (SF) on cytokines during cardiopulmonary bypass (CPB) in infants.
  
  
  METHODS
  Twenty-four infants with congenital heart disease, aged below three years, were randomly assigned to the control group and the SF group equally. In the SF group, 1 mL/kg of SF was given through center vein pump after center vein puncture being performed, while only normal saline was given instead in the control group. Blood sample was obtained for measurement of serum necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) concentration by ELISA, at various time points in the process, i.e. right after anesthesia induction (T1), beginning of CPB (T2), aortic off-clamping (T3), 20 min after CPB (T4), the end of CPB (T5), and 6 h (T6) and 24 h (T7) after CPB.
  
  
  RESULTS
  The time for reverting to sinus heart rhythm and analepsia after CPB was shorter in the SF group than in the control group (P < 0.05). Serum concentration of TNF-a and IL-6 was equal in the two groups at T1; they increased significantly after CPB (P < 0.05), reached the peak value at T4 and reduced to the normal level at T7 in the control group. TNF-alpha concentration was significantly lower at T3, T4 and T5, and IL-6 concentration was lower at T4 in the SF group than that in the control group at corresponding time point (P < 0.05).
  
  
  CONCLUSIONS
  SF could shorten the time for reverting to sinus heart rhythm and analepsia after CPB in infants, and suppress the inflammatory response caused by CPB.
authors: Children's Hospital, Chongqing University of Medical Sciences, Chongqing.
authors: Da-zhen
authors: DZ
authors: Li
authors: Mao
authors: M
authors: Ye
authors: Yin
authors: Y
authors: Xu
mesh_terms: D002315:Cardiopulmonary Bypass; D002675:Child, Preschool; D016207:Cytokines / Q000097:blood*; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006330:Heart Defects, Congenital / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008517:Phytotherapy; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D016207:Cytokines; D004365:Drugs, Chinese Herbal; D015850:Interleukin-6; C492793:Shen-Fu; D014409:Tumor Necrosis Factor-alpha